Insight
External publications
-
'Withers Advises H2 Clipper on New Blockchain Solution to Hydrogen Supply Chain,' The Patent Lawyer - October 8, 2024, quoted
-
'Withers Advises H2 Clipper on New Blockchain Solution to Hydrogen Supply Chain,' Talk of the Town: Attorney at Law Magazine - October 8, 2024, featured
-
'International Law Firm Withers Bergman Upgrades to Larger Boston Office,' Boston Business Journal - May 13, 2024, quoted
-
'Withers Opens New Office In Boston's Financial District,' Law360 - May 10, 2024, quoted
-
'Outsourcing Strategies for Maximizing Drug Exclusivity,' December 19, 2022, co-author
-
'Quality Concerns to Resurface as FDA Resumes Foreign Inspections,' Bloomberg Law - March 17, 2022, quoted
-
'U.S. Senate narrowly confirms Dr. Robert Califf to lead FDA for second time,' Rueters News - February 15, 2022, quoted
-
'Biden's FDA Chief Confirmed by Senate With Republicans' Help,' Bloomberg Law - February 15, 2022, quoted
-
'Patent Filing By Former Employees Leads Pfizer To File Trade Secret Suit,' Pink Sheet - February 3, 2022, quoted
-
'FDA Wants To Make Permanent COVID-19 Supply Chain Guidance To Prevent Product Shortages,' Medtech Insight - January 11, 2022, quoted
-
'FDA's Pfizer Vaccine Approval Adds Fuel to Biden Booster Plan,' Bloomberg Law - August 25, 2021, featured
-
'Withers Picks Red-Hot Kendall Square For New Mass. Office,' Law360 - July 8, 2021, featured
-
'Regulatory Actions for May 19, 2021,' BioWorld - May 19, 2021, featured
-
'Withers Launches Venture Capital and Life Sciences Team in Boston,' Intellectual Property Magazine - April 20, 2021, featured
-
'News Digest: On the Move,' World Trademark Review - April 20, 2021, featured
-
'6 Important Elements Of The New STRONGER Patents Act,' Biosimilar Development - January 2020
-
'FDA Approval and Licensing as Intellectual Property,' Chapter in MCLE publication, Intellectual Property Law - January 2020
-
'Working the Busy Intersection of Law, Science and Business,' Corporate Counsel Business Journal - March 2019
-
'The ABCs of a Product Recall,' Focus Newsletter - December 2014
-
'Maybe it's not the real thing,' Pom Wonderful LLC v Coca-Cola Co (Supreme Court of the US) Case Analysis: Intellectual Property Magazine - July/August 2014
-
'State-by-State Clinical Trial Requirements Reference Guide 2013,' Barnett Educational Services, 2013
-
'Flurry of Supreme Court Decisions Keeps Local IP Bar Busy,' Massachusetts Lawyers Weekly, July 2014, quoted
-
'Managing the Risks and Regulatory Issues Associated with Successful Pharmaceutical Social Media Monitoring and Marketing,' White Paper, September 2007